Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients

Differences in gene expression patterns have been documented not only in Multiple Sclerosis patients versus healthy controls but also in the relapse of the disease. Recently a new gene expression modulator has been identified: the microRNA or miRNA. The aim of this work is to analyze the possible role of miRNAs in multiple sclerosis, focusing on the relapse stage. We have analyzed the expression patterns of 364 miRNAs in PBMC obtained from multiple sclerosis patients in relapse status, in remission status and healthy controls. The expression patterns of the miRNAs with significantly different expression were validated in an independent set of samples. In order to determine the effect of the miRNAs, the expression of some predicted target genes of these were studied by qPCR. Gene interaction networks were constructed in order to obtain a co-expression and multivariate view of the experimental data. The data analysis and later validation reveal that two miRNAs (hsa-miR-18b and hsa-miR-599) may be relevant at the time of relapse and that another miRNA (hsa-miR-96) may be involved in remission. The genes targeted by hsa-miR-96 are involved in immunological pathways as Interleukin signaling and in other pathways as wnt signaling. This work highlights the importance of miRNA expression in the molecular mechanisms implicated in the disease. Moreover, the proposed involvement of these small molecules in multiple sclerosis opens up a new therapeutic approach to explore and highlight some candidate biomarker targets in MS.

[1]  Nan Guo,et al.  PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways , 2006, Nucleic Acids Res..

[2]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[3]  María M. Abad-Grau,et al.  IL2RA/CD25 Gene Polymorphisms: Uneven Association with Multiple Sclerosis (MS) and Type 1 Diabetes (T1D) , 2009, PloS one.

[4]  Mehran Sahami,et al.  Learning Limited Dependence Bayesian Classifiers , 1996, KDD.

[5]  David Baltimore,et al.  MicroRNA-155 is induced during the macrophage inflammatory response , 2007, Proceedings of the National Academy of Sciences.

[6]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[7]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[8]  Sam Griffiths-Jones,et al.  The microRNA Registry , 2004, Nucleic Acids Res..

[9]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[10]  Michel J. Weber.  New human and mouse microRNA genes found by homology search , 2004, The FEBS journal.

[11]  J. Haines,et al.  A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex , 1996, Nature Genetics.

[12]  L. Greller,et al.  Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods , 2004, PLoS biology.

[13]  P. Goodfellow,et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.

[14]  Peter T. Nelson,et al.  MicroRNAs (miRNAs) in Neurodegenerative Diseases , 2008, Brain pathology.

[15]  Mehul M. Vora,et al.  Sequence Relationships among C. elegans, D. melanogaster and Human microRNAs Highlight the Extensive Conservation of microRNAs in Biology , 2008, PloS one.

[16]  Nir Friedman,et al.  Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity , 2004, Annals of neurology.

[17]  R. Ravid,et al.  Increased expression and function of glutamate transporters in multiple sclerosis , 2006, Neurobiology of Disease.

[18]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[19]  Sam Griffiths-Jones,et al.  miRBase: the microRNA sequence database. , 2006, Methods in molecular biology.

[20]  S. Baranzini,et al.  Modular Transcriptional Activity Characterizes the Initiation and Progression of Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[21]  Thomas M. Cover,et al.  Elements of Information Theory , 2005 .

[22]  Yulei N. Wang,et al.  The Genomic Analysis of Erythrocyte microRNA Expression in Sickle Cell Diseases , 2008, PloS one.

[23]  Silke Schmidt,et al.  Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis , 2007, Nature Genetics.

[24]  A. Kurosky,et al.  Leukocyte Reduction, Plasma Apheresis, and Cytomegalovirus DNA Levels in Samples , 2007 .

[25]  C. Poser.  Revisions to the 2001 McDonald diagnostic criteria. , 2006, Annals of neurology.

[26]  M. Ramanathan,et al.  In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects , 2001, Journal of Neuroimmunology.

[27]  C. Croce,et al.  miR-181b negatively regulates activation-induced cytidine deaminase in B cells , 2008, The Journal of experimental medicine.

[28]  C. Matute.  Interaction between glutamate signalling and immune attack in damaging oligodendrocytes. , 2007, Neuron glia biology.

[29]  Pedro Larrañaga,et al.  Detecting reliable gene interactions by a hierarchy of Bayesian network classifiers , 2008, Comput. Methods Programs Biomed..

[30]  Jeffrey S Ross,et al.  miRNA: the new gene silencer. , 2007, American journal of clinical pathology.

[31]  J. Satoh,et al.  Molecular Network Analysis of T-Cell Transcriptome Suggests Aberrant Regulation of Gene Expression by NF-κB As a Biomarker for Relapse of Multiple Sclerosis , 2008, Disease markers.

[32]  L. A. Smith,et al.  Feature Subset Selection: A Correlation Based Filter Approach , 1997, ICONIP.

[33]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[34]  Ryan M. O’Connell,et al.  MicroRNAs: new regulators of immune cell development and function , 2008, Nature Immunology.

[35]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[36]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[37]  S. Mostafavi,et al.  Increased Transcriptional Activity of Milk-Related Genes following the Active Phase of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis1 , 2007, The Journal of Immunology.

[38]  J. Oksenberg,et al.  Multiple sclerosis genetics: leaving no stone unturned , 2005, Genes and Immunity.

[39]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .